Nuntius Therapeutics Patents

Patent portfolio assigned to Nuntius Therapeutics (verified via public assignee records). Estimated patent count: 1. RNA/mRNA therapeutics company using peptide-dendrimer + lipid nanocarriers (London, UK). Patent WO2024028465A1 (hybrid peptide dendrimer systems) listed with assignee Nuntius Therapeutics Ltd -> has_patents true (>=1; additional related PCT filings referenced). Taiho Pharmaceutical is a named development partner (not a paying customer).